Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA, July 17, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX)…
Genix Pharmaceuticals Corporation Announces the Extension of Payment Terms for the Acquisitions of Rights to Renochlor®, Sucanon® and Flu-x™
VANCOUVER, BRITISH COLUMBIA, June 30, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX) (“GENIX”…
Genix Pharmaceuticals Corporation Announces Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA, June 22, 2020 — Genix Pharmaceuticals Corporation (TSX-V: GENX)…
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
DGAP-News: Genix Pharmaceuticals Corp. / Key word(s): Miscellaneous Genix Pharmaceuticals…
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
Vancouver, British Columbia--(Newsfile Corp. - February 14, 2020) - Genix…